Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry-Reference-Cited by-同舟云学术

Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry

Published:2017-12-08 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Horie Kayo¹,Mikami Tetuo²,Yoshida Tsutomu³,Sato Yuichi⁴,Okayasu Isao³

Affiliation:

1. Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan

2. Department of Pathology, Toho University School of Medicine, Ota‑ku, Tokyo 143-8540, Japan

3. Department of Pathology, Kitasato University School of Medicine Sagamihara, Yokohama, Kanagawa 252-0374, Japan

4. Department of Molecular Diagnostics, Kitasato University School of Allied Health Sciences, Sagamihara, Kanagawa 252-0373, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxiredoxin 3 Deficiency Exacerbates DSS-Induced Acute Colitis via Exosomal miR-1260b-Mediated Barrier Disruption and Proinflammatory Signaling;Antioxidants & Redox Signaling;2024-07-29

2. Thioredoxin system in colorectal cancer: Its role in carcinogenesis, disease progression, and response to treatment;Life Sciences;2024-07

3. Voluntary Exercise-Mediated Protection in TNBS-Induced Rat Colitis: The Involvement of NETosis and Prdx Antioxidants;Antioxidants;2023-07-30

4. Contribution of MicroRNAs in the Development of Irritable Bowel Syndrome Symptoms;Journal of Gastrointestinal and Liver Diseases;2023-06-22

5. Protective Effects of H2S Donor Treatment in Experimental Colitis: A Focus on Antioxidants;Antioxidants;2023-04-28